Cargando…

Soluble tumor necrosis factor receptor type 1 predicts cardiorenal outcomes and better associated with distinct cardiovascular or renal outcomes than precedential renal or cardiovascular events in type 2 diabetes mellitus

BACKGROUND: Inflammations are the crucial pathogenesis of chronic complications of type 2 diabetes mellitus (T2DM). OBJECTIVES: The timeline of cardiovascular and renal complications of T2DM and whether soluble tumor necrosis factor receptor type 1 (sTNFR1) levels predict cardiorenal outcomes were s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Li-Hsin, Chu, Chia-Huei, Huang, Chin-Chou, Lin, Liang-Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617259/ https://www.ncbi.nlm.nih.gov/pubmed/37916029 http://dx.doi.org/10.1177/20420188231207345

Ejemplares similares

Cardiovascular and Renal Links along the Cardiorenal Continuum
por: García-Donaire, José A., et al.
Publicado: (2011)

Renal Outcomes in Type 2 Diabetes: A Review of Cardiovascular and Renal Outcome Trials
por: Williams, David M., et al.
Publicado: (2019)

The ankle brachial index exhibits better association with cardiovascular outcomes than interarm systolic blood pressure difference in patients with type 2 diabetes
por: Lin, Liang-Yu, et al.
Publicado: (2019)

Renal injury in cardiorenal syndrome type 1 is mediated by albumin
por: Funahashi, Yoshio, et al.
Publicado: (2022)

Comparison of cardiovascular and renal outcomes between dapagliflozin and empagliflozin in patients with type 2 diabetes without prior cardiovascular or renal disease
por: Lim, Jayoung, et al.
Publicado: (2022)

Kidney-Related Outcome in Cardiorenal Syndrome Type 3
por: Drubel, Kim, et al.
Publicado: (2022)

Value of Renal Histology in Predicting Cardiorenal Outcomes in Heart Transplant–listed Patients
por: Barua, Sumita, et al.
Publicado: (2022)

Association of renal arteriosclerosis and hypertension with renal and cardiovascular outcomes in Japanese type 2 diabetes patients with diabetic nephropathy
por: Shimizu, Miho, et al.
Publicado: (2019)

Renal Assessment in Acute Cardiorenal Syndrome
por: Łagosz, Piotr, et al.
Publicado: (2023)

Cardiorenal syndrome type 4: A study of cardiovascular diseases in chronic kidney disease
por: H., Suresh, et al.
Publicado: (2017)

Characterization of the Oxidative Stress in Renal Ischemia/Reperfusion-Induced Cardiorenal Syndrome Type 3
por: Caio-Silva, Wellington, et al.
Publicado: (2020)

SGLT2 inhibitors in the treatment of type 2 cardiorenal syndrome: Focus on renal tubules
por: Wang, Yajiao, et al.
Publicado: (2023)

Fibroblast Growth Factor 21 Levels Exhibit the Association With Renal Outcomes in Subjects With Type 2 Diabetes Mellitus
por: Chang, Li-Hsin, et al.
Publicado: (2022)

Resting Heart Rate Does Not Predict Cardiovascular and Renal Outcomes in Type 2 Diabetic Patients
por: Bartáková, Vendula, et al.
Publicado: (2016)

International Variability of Renal and Cardiovascular Outcomes and Mortality in Patients with Type 2 Diabetes Mellitus in Europe
por: Thöni, Stefanie, et al.
Publicado: (2023)

Soluble Epoxide Hydrolase Inhibition Prevents Experimental Type 4 Cardiorenal Syndrome
por: Hamzaoui, Mouad, et al.
Publicado: (2021)

Gliflozins for the prevention of stroke in diabetes and cardiorenal diseases: A meta-analysis of cardiovascular outcome trials
por: Zhao, Li-Min, et al.
Publicado: (2021)

Insights Into the Results of Sotagliflozin Cardiovascular Outcome Trials: Is Dual Inhibition the Cherry on the Cake of Cardiorenal Protection?
por: Koufakis, Theocharis, et al.
Publicado: (2021)

Cardiorenal Syndrome Type 5: In Vitro Cytotoxicity Effects on Renal Tubular Cells and Inflammatory Profile
por: Brocca, Alessandra, et al.
Publicado: (2015)

Chronic Heart Failure and Comorbid Renal Dysfunction - A Focus on Type 2 Cardiorenal Syndrome
por: Preeti, Jois, et al.
Publicado: (2016)

Insights of Worsening Renal Function in Type 1 Cardiorenal Syndrome: From the Pathogenesis, Biomarkers to Treatment
por: Fu, Kang, et al.
Publicado: (2021)

Cardiac Spinal Afferent Denervation Attenuates Renal Dysfunction in Rats With Cardiorenal Syndrome Type 2
por: Xia, Zhiqiu, et al.
Publicado: (2022)

Worse cardiovascular and renal outcome in male SLE patients
por: Mihailovic, Jelena, et al.
Publicado: (2023)

Empagliflozin and Cardio-renal Outcomes in Patients with Type 2 Diabetes and Cardiovascular Disease – Implications for Clinical Practice
por: Fitchett, David H
Publicado: (2018)

Association between atherosclerotic cardiovascular diseases risk and renal outcome in patients with type 2 diabetes mellitus
por: Ren, Honghong, et al.
Publicado: (2021)

Cardiorenal Syndrome Type 4—Cardiovascular Disease in Patients with Chronic Kidney Disease: Epidemiology, Pathogenesis, and Management
por: Pateinakis, Panagiotis, et al.
Publicado: (2011)

Comparative efficacy of 5 sodium glucose cotransporter 2 inhibitor and 7 glucagon-like peptide 1 receptor agonists interventions on cardiorenal outcomes in type 2 diabetes patients: A network meta-analysis based on cardiovascular or renal outcome trials
por: Duan, Xue-Yan, et al.
Publicado: (2021)

Nicorandil Decreases Renal Injury in Patients With Coronary Heart Disease Complicated With Type I Cardiorenal Syndrome
por: Du, Xiaozhi, et al.
Publicado: (2021)

Excessive fibroblast growth factor 23 promotes renal fibrosis in mice with type 2 cardiorenal syndrome
por: Hao, Huixin, et al.
Publicado: (2021)

Prediction of cardiovascular outcomes with machine learning techniques: application to the Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL) study
por: Chen, Tian, et al.
Publicado: (2019)

Comprehensive Cardiovascular and Renal Protection in Patients with Type 2 Diabetes
por: Castro Conde, Almudena, et al.
Publicado: (2023)

Exacerbation of Renal, Cardiovascular, and Respiratory Outcomes Associated with Changes in Climate
por: Baraghoshi, David, et al.
Publicado: (2023)

Cardiovascular Alterations and Structural Changes in the Setting of Chronic Kidney Disease: a Review of Cardiorenal Syndrome Type 4
por: Minciunescu, Andrei, et al.
Publicado: (2022)

Acute Childhood Cardiorenal Syndrome and Impact of Cardiovascular Morbidity on Survival
por: Olowu, Wasiu A.
Publicado: (2011)

Cardiovascular outcomes in type 1 and type 2 diabetes
por: Rosengren, Annika, et al.
Publicado: (2023)

Risk factors and outcome variables of cardiorenal syndrome type 1 from the nephrologist’s perspective
por: Seckinger, Dominik, et al.
Publicado: (2021)

Blood Pressure and Cardiorenal Outcomes With Finerenone in Chronic Kidney Disease in Type 2 Diabetes
por: Ruilope, Luis M., et al.
Publicado: (2022)

Cardiovascular risks in type 2 diabetes and the interpretation of cardiovascular outcome trials
por: Hinnen, Deborah, et al.
Publicado: (2019)

Sodium–Glucose Cotransporter 2 Inhibitor Protection Against Adverse Cardiovascular and Renal Outcomes in Patients With Type 2 Diabetes
por: Shahady, Edward, et al.
Publicado: (2019)

Changes in Albuminuria Predict Cardiovascular and Renal Outcomes in Type 2 Diabetes: A Post Hoc Analysis of the LEADER Trial
por: Persson, Frederik, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ueaipir7ui670gr3n43paselih